- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Progyny Inc (PGNY)
Progyny Inc stock price live, this page displays NASDAQ PGNY stock exchange data. View the PGNY premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Progyny Inc real time stock price chart below.
What Is the Progyny Inc Stock Price Today?
The Progyny Inc stock price today is 30.21.
What Is the Stock Symbol for Progyny Inc?
The stock symbol for Progyny Inc is "PGNY."
What Stock Exchange Does Progyny Inc Trade On?
Progyny Inc is listed and trades on the NASDAQ stock exchange.
Is Progyny Inc a Good Stock to Buy?
Determining whether Progyny Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PGNY quote. (ISIN: US74340E1038)
What Is the Progyny Inc Stock Price Today?
The Progyny Inc stock price today is 30.21.
What Is the Stock Symbol for Progyny Inc?
The stock symbol for Progyny Inc is "PGNY."
What Stock Exchange Does Progyny Inc Trade On?
Progyny Inc is listed and trades on the NASDAQ stock exchange.
Is Progyny Inc a Good Stock to Buy?
Determining whether Progyny Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PGNY quote. (ISIN: US74340E1038)
Fair Value
An estimate of a Progyny's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
30.15
31.43
52 wk Range
16.10
33.06
Unusual Pre-Market activity
1/2
Fair Value
An estimate of a Progyny's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
30.1531.43
52 wk Range
16.1033.06
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PGNY Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Progyny's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
33.91
Upside
+12.24%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Holds more cash than debt on its balance sheet
Progyny Inc receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Progyny Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
9 Buy
2 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 33.91
(+12.24% Upside)
Progyny Inc SWOT Analysis
Market Dominance | Progyny leads the expanding fertility benefits market, projecting revenue of $1.185-$1.235 billion for 2025 amid strong client growth and service adoption. |
Financial Health | Explore Progyny's robust financials, including a 3.34 health score, strong cash flow yields, and a clean balance sheet primed for future growth. |
Analyst Perspectives | Delve into varied analyst views, with price targets ranging from $21 to $30, reflecting cautious optimism about Progyny's market position and growth potential. |
Strategic Expansion | Learn how Progyny's new offerings in maternity and menopause care, alongside payor partnerships, could significantly boost annual revenue by 2028. |
Progyny Inc Earnings Call Summary for Q2/2026
- Progyny posted Q2 2026 adjusted EPS of $0.55 vs. $0.34 est., revenue of $350.5M vs. $348.7M est.; shares fell 15.59% after hours to $25.50.
- Company reiterated FY 2026 revenue guidance of $1.36B-$1.385B and adjusted EPS of $2.04-$2.10 despite beating Q2 estimates by 61.8% on earnings.
- Management cited more pronounced summer slowdown affecting Q3, guiding $335M-$345M revenue and $56M-$59M adjusted EBITDA for the quarter.
- Gross margin expanded 180 bps YoY; company generated $201M operating cash flow TTM with zero debt and $237M cash; repurchased 2M shares in quarter.
- CEO Anevski noted competitive conversions accelerating among cost-conscious employers; new Progyny Select product expected immaterial for 2027.
Last Updated: 06/08/2026, 22:56
Read Full TranscriptEarnings
Latest Release
Aug 06, 2026
EPS / Forecast
0.55 / 0.34
Revenue / Forecast
350.51M / 348.69M
Compare PGNY to Peers and Sector
Metrics to compare | PGNY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPGNYPeersSector | |
|---|---|---|---|---|
P/E Ratio | 35.0x | −2.8x | −0.4x | |
PEG Ratio | 1.00 | 0.64 | 0.00 | |
Price/Book | 5.4x | 2.8x | 2.6x | |
Price / LTM Sales | 1.8x | 1.2x | 3.0x | |
Upside (Analyst Target) | 12.5% | 22.1% | 50.7% | |
Fair Value Upside | Unlock | 19.7% | 7.2% | Unlock |
Progyny, Inc., a benefits management company, provides fertility, family building, and women’s health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Progyny (PGNY) Stock Price Today?
The Progyny stock price today is 30.21 USD.
What Stock Exchange Does Progyny Trade On?
Progyny is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Progyny?
The stock symbol for Progyny is "PGNY."
What Is the Progyny (PGNY) Afterhours Price Today? (Afterhours variable test: 26.14) Current Date: Aug 07, 2026
After hours price: 26.14. After hours price change (units): -4.03. Price change percentage: -13.36%
What Is the Progyny Market Cap?
As of today, Progyny market cap is 2.37B USD.
What Is Progyny's Earnings Per Share (TTM)?
The Progyny EPS (TTM) is 0.76.
When Is the Next Progyny Earnings Date?
Progyny will release its next earnings report on Oct 29, 2026.
From a Technical Analysis Perspective, Is PGNY a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Progyny Stock Split?
Progyny has split 0 times.
How Many Employees Does Progyny Have?
Progyny has 846 employees.
What is the current trading status of Progyny (PGNY)?
As of Aug 07, 2026, Progyny (PGNY) is trading at a price of 30.21 USD, with a previous close of 30.21 USD. The stock has fluctuated within a day range of 30.15 USD to 31.43 USD, while its 52-week range spans from 16.10 USD to 33.06 USD.
What Is Progyny (PGNY) Price Target According to Analysts?
The average 12-month price target for Progyny is 33.91 USD, with a high estimate of 40 USD and a low estimate of 27 USD. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +12.24% Upside potential.
What Is the PGNY Premarket Price?
PGNY's last pre-market stock price is 25.79 USD. The pre-market share volume is 240.00, and the stock has decreased by -4.42, or -14.63%.
What Is the PGNY After Hours Price?
PGNY's last after hours stock price is 26.14 USD, the stock has decreased by -4.03, or -13.36%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.